1. When to Suspect Hidden Hypercortisolism in Type 2 Diabetes: A Meta-Analysis
- Author
-
Rosario Pivonello, Davide Soranna, Chiara Parazzoli, Dan Einhorn, Jens Otto Lunde Jørgensen, Vittoria Favero, Antonella Zambon, Alfredo Scillitani, David Brown, Iacopo Chiodini, Lewis S. Blevins, Luca Giovanelli, Carmen Aresta, Luigi Gennari, Kevin M. Pantalone, Luca Persani, Aresta, C, Soranna, D, Giovanelli, L, Favero, V, Parazzoli, C, Gennari, L, Persani, L, Scillitani, A, Blevins, L, Brown, D, Einhorn, D, Pivonello, R, Pantalone, K, Lunde Jorgensen, J, Zambon, A, Chiodini, I, Aresta, C., Soranna, D., Giovanelli, L., Favero, V., Parazzoli, C., Gennari, L., Persani, L., Scillitani, A., Blevins, L. S., Brown, D., Einhorn, D., Pivonello, R., Pantalone, K. M., Lunde Jorgensen, J. O., Zambon, A., and Chiodini, I.
- Subjects
Cortisol secretion ,medicine.medical_specialty ,insulin ,hypertension ,ADRENAL INCIDENTALOMAS ,Endocrinology, Diabetes and Metabolism ,Type 2 diabetes ,MELLITUS ,Endocrinology ,Diabetes mellitus ,Internal medicine ,SUBCLINICAL CUSHINGS-SYNDROME ,Odds Ratio ,Prevalence ,Medicine ,Humans ,ADULT PATIENTS ,Cushing Syndrome ,diabetes ,hypercortisolism ,POPULATION ,Subclinical infection ,RISK ,business.industry ,CORTISOL ,nutritional and metabolic diseases ,Odds ratio ,medicine.disease ,INCREASED MORTALITY ,Confidence interval ,PREVALENCE ,Diabetes Mellitus, Type 2 ,diabete ,Research Design ,Meta-analysis ,business ,OUTPATIENTS ,Dyslipidemia ,Human - Abstract
Objective Among patients with type 2 diabetes (T2D), the prevalence of hidden hypercortisolism (HidHyCo, formally called subclinical hypercortisolism or mild autonomous cortisol secretion) was estimated to be 2.2-12.1%. The aim of this study was to investigate whether the available literature helps to identify the characteristics of T2D patients more frequently associated with HidHyCo. Methods A meta-analysis was performed using studies that assessed both the prevalence of HidHyCo in patients with T2D and the characteristics of these patients with and without HidHyCo. The DerSimonian and Laird (DSL) and the Hartung, Knapp, Sidik and Jonkman (HKSJ) methods were utilized. Results Among the 18 available studies, 6 studies provided the necessary data. The association between HidHyCo and advanced T2D (based on the patients’ description given in each study in presence of micro/ microvascular complications, or insulin treatment plus hypertension, or hypertension treated with ≥2 drugs), hypertension, insulin treatment and dyslipidemia was reported in 5 (2184 patients), 6 (2283 patients), 3 (1440 patients), and 3 (987 patients) studies, respectively. HidHyCo was associated with advanced T2D as assessed with both DSL (odds ratio, OR, 3.47, 95% Confidence Interval, 95%CI, 2.12-5.67) and HKSJ method (OR 3.60, 95%CI 2.03-6.41) and with the prevalence of hypertension or of insulin treatment as assessed by the DSL approach (OR 1.92, 95%CI 1.05-3.50 and OR 2.29, 95%CI 1.07-4.91, respectively), but not as assessed with HKSJ method. Conclusions Patients with advanced T2D have a higher prevalence of HidHyCo. These data inform about the selection of T2D patients for HidHyCo screening.
- Published
- 2021
- Full Text
- View/download PDF